Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer: A Multicenter, Randomized, Double-Blind, Phase III Trial von Prabhash, Kumar, Deshmukh, Chetan, Malhotra, Hemant, Sharma, Atul, Jain, Minish, Dhamne, Nilesh, Nagarakar, Rajnish, Ganesan, Prasantha, Mahobia, Vijay K, Das, Chandan K, Kumar, Rejnish, Shivanna, Prakash S, Avaronnan, Manu P, Chaithanya, Puligundla K, Chaudhary, Vaibhav, Singh, Kartar, Aagre, Suhas, Ravishankar, Bellala, Mehta, Dhruv, Shilpa, Kandipalli, Maniar, Vashishth, Chatterjee, Koushik, Majumdar, Saroj D, Dana, Rohitashwa, Noronha, Vanita, Menon, Nandini, Sharma, Akhilesh, Pawar, Roshan, Shahavi, Vinayaka, Yadav, Rajiv, Aiwale, Amol

Volltext